What is Cetuximab?

Category: Prescription Drugs

Most popular types: Erbitux

false

Cetuximab is an antineoplastic agent, epidermal growth factor receptor (EGFR) inhibitor. It may be used for the treatment of metastatic colorectal cancer and cancer of the head and neck, but may also be used for EGFR-positive non-small cell lung cancer and certain types of skin cancer.

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
0
Moderate
3
Mild
1
None
0

Commonly reported side effects and conditions associated with Cetuximab

Side effect Patients
Alternating constipation and diarrhea 1
Dry skin 1
Rashes (redness, swelling) 1

Dosages

Based on patients currently taking Cetuximab

Dosage Patients
600 mg/m2 weekly 1

Why patients stopped taking Cetuximab

Multiple reasons could be selected

Reason Patients
Course of treatment ended 1
See all 2 patients who've stopped taking Cetuximab

Duration

Currently taking Cetuximab

Duration Patients
6 months - 1 year 1

Stopped taking Cetuximab

Duration Patients
1 - 6 months 2
Adherence
Adherence Evaluations
Always 3
Usually 1
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 1
Somewhat hard to take 1
A little hard to take 1
Not at all hard to take 1
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 1
$25-49 0
< $25 3
Not specified 0

What people switch to and from

Patients started taking Cetuximab after stopping:

Treatment Patients
Docetaxel-carboplatin-trastuzumab (TCH) 1
Last updated:
There are no evaluations for Cetuximab.